{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T18:16:38Z","timestamp":1759342598504},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"S12","license":[{"start":{"date-parts":[[1996,12,1]],"date-time":"1996-12-01T00:00:00Z","timestamp":849398400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Digest Dis Sci"],"published-print":{"date-parts":[[1996,12]]},"DOI":"10.1007\/bf02087887","type":"journal-article","created":{"date-parts":[[2005,8,14]],"date-time":"2005-08-14T11:36:04Z","timestamp":1124019364000},"page":"121S-125S","source":"Crossref","is-referenced-by-count":7,"title":["Managing patients on interferon therapy"],"prefix":"10.1007","volume":"41","author":[{"given":"Rafael","family":"Esteban","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"BF02087887_CR1","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1056\/NEJM199506013322201","volume":"332","author":"T Poynard","year":"1995","unstructured":"Poynard T, Bedossa P, Chevallier M, Mathurin P, Lemonnier C, Trepo C, Couzigou P, Payeu JL, Sajus M, Costa JM, Vidaud M, Chaput JC, and the Multicenter Study Group: A comparison of three interferon alfa-2b regimens for the long-term treatment of chronic non-A, non-B hepatitis. N Engl J Med 332:1457\u20131462, 1995","journal-title":"N Engl J Med"},{"key":"BF02087887_CR2","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1056\/NEJM199104043241401","volume":"324","author":"A Castilla","year":"1991","unstructured":"Castilla A, Prieto J, Fausto N: Transforming growth factors\u03b21 and\u03b1 in chronic liver disease. Effects of interferon alfa therapy. N Engl J Med 324:933\u2013940, 1991","journal-title":"N Engl J Med"},{"key":"BF02087887_CR3","doi-asserted-by":"crossref","first-page":"115","DOI":"10.2165\/00002018-199410020-00003","volume":"2","author":"T Vial","year":"1994","unstructured":"Vial T, Descotes J: Clinical toxicity of the interferons. Drug Safety 2:115\u2013150, 1994","journal-title":"Drug Safety"},{"key":"BF02087887_CR4","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1055\/s-2008-1040523","volume":"9","author":"PF Renault","year":"1989","unstructured":"Renault PF, Hoofnagle JH: Side effects of alpha interferon. Semin Liver Dis 9:273\u2013277, 1989","journal-title":"Semin Liver Dis"},{"key":"BF02087887_CR5","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1001\/archinte.1987.00370090055011","volume":"147","author":"PF Renault","year":"1987","unstructured":"Renault PF, Hoofnagle JH, Park Y, Mullen KD, Peters M, Jones DB, Rustgi V, Jones A: Psychiatric complications of long-term interferon alfa therapy. Arch Intern Med 147:1577\u20131580, 1987","journal-title":"Arch Intern Med"},{"key":"BF02087887_CR6","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1378\/chest.99.3.557","volume":"99","author":"M Sonnenblick","year":"1991","unstructured":"Sonnenblick M, Rosin A: Cardiotoxicity of interferon. A review of 44 cases. Chest 99:557\u2013561, 1991","journal-title":"Chest"},{"key":"BF02087887_CR7","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.1016\/0016-5085(92)90348-3","volume":"102","author":"M Lisker-Melman","year":"1992","unstructured":"Lisker-Melman M, Di Bisceglie AM, Usala SJ, Weintraub B, Murray LM, Hoofnagle JH: Development of thyroid disease during therapy of chronic viral hepatitis with interferon alpha. Gastroenterology 102:2155\u20132160, 1992","journal-title":"Gastroenterology"},{"key":"BF02087887_CR8","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1136\/gut.33.6.855","volume":"33","author":"P Marcellin","year":"1992","unstructured":"Marcellin P, Pouteau M, Renard P, Grynblat J-M, Colas Linhart N, Bardet P, Bok B, Benhamou J-P: Sustained hypothyroidism induced by recombinant\u03b1 interferon in patients with chronic hepatitis C. Gut 33:855\u2013856, 1992","journal-title":"Gut"},{"key":"BF02087887_CR9","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1111\/j.1365-2265.1993.tb02423.x","volume":"39","author":"E Baudin","year":"1993","unstructured":"Baudin E, Marcellin P, Pouteau M, Colas-Linhart N, Le Floch J-P, Lemonnier C, Benhamou J-P, Bok B: Reversibility of thyroid dysfunction induced by recombinant alpha interferon in chronic hepatitis C. Clin Endocrinol 39:657\u2013661, 1993","journal-title":"Clin Endocrinol"},{"key":"BF02087887_CR10","doi-asserted-by":"crossref","first-page":"51","DOI":"10.7326\/0003-4819-116-1-51","volume":"116","author":"T Papo","year":"1992","unstructured":"Papo T, Marcellin P, Bernuau J, Durand F, Poynard T, Benhamou J-P: Autoimmune chronic hepatitis exacerbated by alpha-interferon. Ann Intern Med 116:51\u201353, 1992","journal-title":"Ann Intern Med"},{"key":"BF02087887_CR11","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1002\/hep.1840160304","volume":"16","author":"F Lunel","year":"1992","unstructured":"Lunel F, Abauf N, Franguel L, Grippon P, Perrin M, Coz YL, Valla D, Borotto E, Yamamoto A-M, Huraux J-M, Opolon P, Homberg J-C: Liver\/kidney microsome antibody type 1 and hepatitis C virus infection. Hepatology 16:630\u2013636, 1992","journal-title":"Hepatology"},{"key":"BF02087887_CR12","first-page":"613","volume":"21","author":"BD Clifford","year":"1995","unstructured":"Clifford BD, Donahue D, Smith L, Cable E, Luttig B, Manns M, Bonkovsky HL: High prevalence of serological markers of autoimmunity in patients with chronic hepatitis C. Hepatology 21:613\u2013619, 1995","journal-title":"Hepatology"},{"key":"BF02087887_CR13","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1378\/chest.106.2.612","volume":"106","author":"K Ogata","year":"1994","unstructured":"Ogata K, Koga T, Yagawa K: Interferon-related bronchiolitis obliterans organizing pneumonia. Chest 106:612\u2013613, 1994","journal-title":"Chest"},{"key":"BF02087887_CR14","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1001\/archopht.1993.01090030068041","volume":"111","author":"D Guyer","year":"1993","unstructured":"Guyer D, Tiedeman J, Yannuzzi LA, Slakter JS, Parke D, Kelley J, Tang RA, Marmor M, Abrams G, Miller JW, Gragoudas ES: Interferon-associated retinopathy. Arch Ophthalmol 111:350\u2013356, 1993","journal-title":"Arch Ophthalmol"},{"key":"BF02087887_CR15","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1002\/jmv.1890450411","volume":"45","author":"R Lesniewski","year":"1995","unstructured":"Lesniewski R, Okasinski G, Carrick R, Van Sant C, Desai S, Johnson R, Scheffel J, Moore B, Mushahwar I: Antibody to hepatitis C virus second envelope (HCV-E2) glycoprotein: A new marker of HCV infection closely associated with viremia. J Med Virol 45:415\u2013422, 1995","journal-title":"J Med Virol"},{"key":"BF02087887_CR16","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1093\/clinchem\/39.4.725","volume":"39","author":"MS Urdea","year":"1993","unstructured":"Urdea MS: Synthesis and characterization of branched DNA (bDNA) for the direct and quantitative detection of CMV, HBV, HCV, and HIV. Clin Chem 39:725\u2013726, 1993","journal-title":"Clin Chem"},{"key":"BF02087887_CR17","doi-asserted-by":"crossref","first-page":"321","DOI":"10.7326\/0003-4819-123-5-199509010-00001","volume":"123","author":"DR Gretch","year":"1995","unstructured":"Gretch DR, dela Rosa C, Carithers RL, Willson RA, Williams B, Corey L: Assessment of hepatitis C viremia using molecular amplification technologies: correlations and clinical implications. Ann Intern Med 123:321\u2013329, 1995","journal-title":"Ann Intern Med"},{"key":"BF02087887_CR18","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1002\/jmv.1890460205","volume":"46","author":"E Orito","year":"1995","unstructured":"Orito E, Mizokami M, Suzuki K, Ohba K, Ohno T, Mori M, Hayashi K, Kato K, Iino S, Lau JYN: Loss of serum HCV RNA at week 4 of interferon-\u03b1 therapy is associated with more favorable long-term response in patients with chronic hepatitis C. J Med Virol 46:109\u2013115, 1995","journal-title":"J Med Virol"}],"container-title":["Digestive Diseases and Sciences"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02087887.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF02087887\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02087887","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,9]],"date-time":"2020-04-09T00:50:31Z","timestamp":1586393431000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF02087887"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1996,12]]},"references-count":18,"journal-issue":{"issue":"S12","published-print":{"date-parts":[[1996,12]]}},"alternative-id":["BF02087887"],"URL":"https:\/\/doi.org\/10.1007\/bf02087887","relation":{},"ISSN":["0163-2116","1573-2568"],"issn-type":[{"value":"0163-2116","type":"print"},{"value":"1573-2568","type":"electronic"}],"subject":[],"published":{"date-parts":[[1996,12]]}}}